Pipeline

Product Therapeutic Area Phase 1 Phase 2 Phase 3 NDA Approved
Ongoing
Planned

Commercial

Abstral® (fentanyl) Sublingual Tablets Breakthrough Cancer Pain
Zuplenz® (ondansetron) Oral Soluble Film Antiemetic for CINV, RINV, PONV

Immunotherapy

NeuVax™ Breast cancer node-positive, HER2 IHC 1+/2+
NeuVax™ + Herceptin® Breast cancer node-positive & triple negative, HER2 IHC 1+/2+
NeuVax™ + Herceptin® Breast cancer neoadjuvant, node-positive & negative, HER2 IHC 3+
NeuVax™ Gastric carcinoma HER2 IHC 1+/2+ or 3+
GALE-301 (Folate Binding Protein) Ovarian & Endometrial Cancers

Hematology

GALE-401 (Anagrelide CR) MPN-related thrombocytosis

*NeuVax is an investigational product.  Efficacy has not been established.